ASND - Ascendis Pharma A S Stock Trading

Ascendis Pharma A/S(NASDAQ: ASND) stock trading description contact officers and directors.

About Ascendis Pharma A/S

Not available

Stock Information

Ascendis Pharma A/S Company Name:

ASND Stock Symbol:

NASDAQ Market:

Ascendis Pharma A/S Website:

Get ASND Alerts

News, Short Squeeze, Breakout and More Instantly...

ASND - Ascendis Pharma A/S Reports Second Quarter 2022 Financial Results

— U.S. regulatory submission for TransCon PTH, designed to be the first parathyroid hormone replacement therapy, on track for Q3 2022; EU submission planned for Q4 2022 — SKYTROFA revenue continued to double quarter-to-quarter, reaching Ȋ...
ASND - Ascendis Pharma A/S Announces Second Quarter 2022 Financial Results and Business Update Conference Call on August 10

COPENHAGEN, Denmark, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) announced today that the company will hold a conference call and live webcast on Wednesday, August 10, 2022, at 4:30 p.m. Eastern Time (ET) to review its second quarter 2022 financial results and provi...
ASND - Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon(TM) PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022

– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral presentation of TransCon PTH Phase 2 PaTH Forward Trial Open-Label Extension Data in adult hypoparathyroidism on ...